🌅 Today's Morning Call
|
S&P Futures
6,742.75
▲ +38.00 (+0.57%)
|
Nasdaq Futures
24,816.50
▲ +140.75 (+0.57%)
|
Dow Futures
47,240.00
▲ +256.00 (+0.54%)
|
|
10Y Treasury
4.22%
▼ -0.06%
|
US Dollar
99.80
▼ -0.13 (-0.13%)
|
Bitcoin
$74,056
▼ -$805 (-1.08%)
|
Data as of 8:08 AM ET
Good morning! Futures are pointing to a positive open this Tuesday morning, with all three major indexes climbing more than half a percent before the bell. Pfizer's breakthrough cancer trial data is stealing headlines in healthcare, while Delta's upbeat travel commentary and Amazon's delivery ambitions are adding fuel to the rally. Here's what's moving markets this morning.
👀 What to Watch Today
The Federal Reserve decision looms large on this week's calendar, with investors parsing every data point and inflation signal before Wednesday's policy announcement. Treasury yields pulled back overnight, with the 10-year dropping to 4.22%, giving equity markets a bit of breathing room ahead of the Fed's verdict.Middle East tensions continue to simmer beneath the surface, with oil prices ticking higher and British Airways extending flight suspensions to key regional hubs through late May. The geopolitical backdrop adds a layer of uncertainty, but so far, equity traders are shaking off the concern in favor of solid corporate news.
Watch for any commentary from Fed officials in the blackout period's final hours, plus continued developments on the TotalEnergies settlement story. The proposed $1 billion payout over canceled wind farm projects could set a precedent for how the U.S. handles energy infrastructure disputes with foreign companies.
🌏 Overnight Recap
Asian markets closed mixed overnight, with Tokyo and Hong Kong showing modest gains while mainland China indices struggled for direction. Investors across the Pacific are similarly positioned ahead of central bank decisions, with the Bank of Japan maintaining its dovish stance while the Fed prepares to speak Wednesday.European bourses opened higher this morning, taking cues from the positive pre-market momentum in U.S. futures. London's FTSE and Germany's DAX both climbed in early trading, supported by easing bond yields and relief that energy prices haven't spiked further despite ongoing Middle East flight disruptions.
The dollar index slipped to 99.80, down modestly as traders rotate into risk assets. Bitcoin dipped just over 1% to around $74,056, consolidating after recent gains but holding well above key technical support levels.
Sponsored Content
Gold Beats U.S. Treasuries And Could Make Your Income Soar
While the world's central banks dump America's bonds for gold, one income expert reveals a quiet $15 fund turning that shift into massive monthly income, up to $1,152 every month.
📊 Pre-Market Movers
Pfizer (PFE) is catching a strong bid in pre-market trading after announcing its experimental combination treatment reduced breast cancer progression or death risk by 40% in trial patients. The data represents a significant win for the pharmaceutical giant's oncology pipeline and could reshape treatment protocols if the results hold through later-stage trials.Stryker (SYK) is drawing attention after confirming it contained a cyberattack that disrupted operations across its network. The medical device maker says it's now focused on restoring customer-related systems, a reassuring signal that the breach didn't cause permanent damage or data loss. Cybersecurity stocks could see sympathy momentum.
Delta Air Lines (DAL) is holding steady after CEO Ed Bastian told CNBC that travel demand remains exceptionally strong despite the carrier posting a $400 million Q4 loss. The company reaffirmed its Q1 forecast, suggesting the spring travel season is shaping up nicely. Amazon (AMZN) is also in focus after launching one-hour and three-hour delivery windows in select U.S. markets, doubling down on its logistics advantage.
🔍 Today's Watchlist
- Federal Reserve commentary and any last-minute signals before Wednesday's decision
- Pfizer (PFE) reaction to 40% breast cancer progression risk reduction data
- Airlines sector strength following Delta's (DAL) upbeat demand outlook
- Treasury yield movements as 10-year sits at 4.22% ahead of Fed
- Cybersecurity focus after Stryker (SYK) contains network attack
Sponsored Content
Iran Conflict Reveals Trump's Most Powerful Weapon
It's not missiles. It's not sanctions. It’s not tariffs. It’s a commodity found in the Appalachian Mountains. America controls 80% of the one material every enemy nation needs to build advanced technology — semiconductors, AI chips, military electronics. Trump is expected to weaponize this monopoly with an export ban that cuts off China and Iran overnight. Morgan Stanley estimates the reshoring boom triggers a $10 trillion transformation.
🎯 The Morning Playbook
Today's setup favors selective buying in healthcare and travel names, with Pfizer's clinical win and Delta's demand commentary providing clear fundamental catalysts. The pullback in Treasury yields gives growth stocks a bit more oxygen, though the Fed decision Wednesday means traders won't get too aggressive with new positions just yet.Keep an eye on how the market digests the Stryker cyberattack news. Contained breaches are becoming more common, and the stock's reaction could signal whether investors are growing numb to these incidents or still treating them as material risks. The TotalEnergies settlement talks also highlight how policy decisions around energy infrastructure can create billion-dollar consequences.
With futures pointing higher and volatility subdued, this could be a quiet grind upward into the close. Don't chase the open. Let the first hour settle, watch how the market handles resistance levels, and remember that Wednesday's Fed announcement is the real event risk this week. Stay patient, stay focused, and keep your shopping list ready for post-Fed opportunities.